The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase III, randomized, open-label, multicenter trial (BREAK-3) comparing the BRAF kinase inhibitor dabrafenib (GSK2118436) with dacarbazine (DTIC) in patients with BRAFV600E-mutated melanoma.
Axel Hauschild
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Jean Jacques Grob
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline
Lev V. Demidov
Honoraria - GlaxoSmithKline; MSD
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Pfizer; Roche
Thomas Jouary
Consultant or Advisory Role - Bristol-Myers Squibb; Roche
Honoraria - Bristol-Myers Squibb; Roche
Ralf Gutzmer
Consultant or Advisory Role - Almirall Hermal GmbH; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis
Honoraria - Almirall Hermal GmbH; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; Roche
Research Funding - Novartis; Roche
Other Remuneration - Bristol-Myers Squibb; MSD; Roche
Michael Millward
Consultant or Advisory Role - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Piotr Rutkowski
Consultant or Advisory Role - Bristol-Myers Squibb; Novartis
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Pfizer
Christian U. Blank
Consultant or Advisory Role - Bristol-Myers Squibb; Novartis; Roche
Research Funding - Bristol-Myers Squibb; Novartis
Beloo Mirakhur
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Mary E. Guckert
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
R. Suzanne Swann
Employment or Leadership Position - GlaxoSmithKline
Patricia Haney
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Anne-Marie Martin
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Danielle Ouellet
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Kelly Grotzinger
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Vicki L. Goodman
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Paul B. Chapman
Consultant or Advisory Role - GlaxoSmithKline; Roche/Genentech
Research Funding - GlaxoSmithKline; Roche/Genentech